Landmark Clinical Research With the On-X Life Technologies, Inc. Heart Valve in a Poorly Anticoagulated South African Patient Group to be Presented at Major U.S. Heart Centers
9/1/2011 10:11:10 AM
AUSTIN, Texas, Sept. 1, 2011 (GLOBE NEWSWIRE) -- On-X® Life Technologies, Inc. (On-X LTI) announced today that Mervyn Williams, M.D., of Port Elizabeth, South Africa, will present the results of a Ten-year Clinical Study with the On-X® Prosthetic Heart Valve in Poorly Anticoagulated Patients in South Africa. The study of these marginally compliant patients has led to the view that the On-X valve may be able to adapt to fluctuations in anticoagulation with all types of patients.
comments powered by